Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Kwak

Concepts (172)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fluorodeoxyglucose F18
11
2024
165
1.340
Why?
Positron-Emission Tomography
13
2024
342
1.330
Why?
Sentinel Lymph Node
5
2019
49
1.090
Why?
Sentinel Lymph Node Biopsy
6
2019
117
1.040
Why?
Melanoma
9
2024
764
0.960
Why?
Head and Neck Neoplasms
5
2019
563
0.770
Why?
Skin Neoplasms
6
2019
805
0.760
Why?
Fever of Unknown Origin
1
2023
13
0.760
Why?
Multimodal Imaging
6
2016
138
0.740
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
15
0.740
Why?
Radiopharmaceuticals
11
2024
210
0.720
Why?
Lung Neoplasms
10
2025
2674
0.650
Why?
Thyroid Neoplasms
3
2020
380
0.650
Why?
Lymphoscintigraphy
2
2019
10
0.640
Why?
Graves Disease
1
2020
32
0.640
Why?
Four-Dimensional Computed Tomography
5
2025
38
0.600
Why?
Spirituality
1
2020
88
0.570
Why?
Positron Emission Tomography Computed Tomography
6
2024
122
0.550
Why?
Chemoradiotherapy, Adjuvant
2
2016
44
0.500
Why?
Iodine Radioisotopes
4
2020
139
0.450
Why?
Hamartoma
1
2015
29
0.420
Why?
Rectal Neoplasms
1
2016
159
0.420
Why?
Radiotherapy Planning, Computer-Assisted
4
2025
150
0.410
Why?
Tomography, X-Ray Computed
7
2016
2766
0.410
Why?
Diagnostic Imaging
1
2015
340
0.350
Why?
Lymphoma
2
2026
251
0.310
Why?
Radiation Pneumonitis
2
2021
31
0.310
Why?
Immunotherapy
1
2015
669
0.300
Why?
Neoplasm Recurrence, Local
4
2020
1156
0.290
Why?
Adenocarcinoma
1
2016
927
0.280
Why?
Lung
5
2023
4119
0.280
Why?
Chemoradiotherapy
2
2020
238
0.260
Why?
Neuroendocrine Tumors
2
2022
122
0.260
Why?
Lymph Node Excision
2
2019
173
0.250
Why?
Respiratory-Gated Imaging Techniques
2
2016
10
0.240
Why?
Tomography, Emission-Computed, Single-Photon
4
2023
104
0.220
Why?
Radioisotopes
3
2024
37
0.220
Why?
alpha-MSH
1
2024
6
0.210
Why?
Lutetium
1
2024
5
0.210
Why?
Humans
36
2026
145625
0.200
Why?
Ibuprofen
1
2024
86
0.200
Why?
Computer Simulation
2
2026
1014
0.190
Why?
Lymphatic Metastasis
3
2019
335
0.190
Why?
Esophageal Neoplasms
2
2018
351
0.190
Why?
Medical Oncology
1
2026
344
0.180
Why?
Radiotherapy, Intensity-Modulated
2
2025
143
0.180
Why?
Precision Medicine
1
2026
462
0.170
Why?
Aged
14
2025
26251
0.170
Why?
Methimazole
1
2020
5
0.160
Why?
Antithyroid Agents
1
2020
12
0.160
Why?
Retrospective Studies
10
2022
17291
0.160
Why?
Image Processing, Computer-Assisted
1
2025
774
0.160
Why?
Machine Learning
1
2026
590
0.150
Why?
Image-Guided Biopsy
1
2019
41
0.150
Why?
Religion
1
2020
64
0.150
Why?
Nuclear Medicine
1
2019
9
0.150
Why?
Treatment Failure
1
2020
358
0.150
Why?
Middle Aged
15
2025
36359
0.150
Why?
Scalp
1
2019
38
0.150
Why?
Radionuclide Imaging
1
2019
116
0.150
Why?
Neoplasms
1
2015
2944
0.140
Why?
Thyroid Gland
1
2019
93
0.140
Why?
Skin Pigmentation
1
2019
44
0.140
Why?
Aged, 80 and over
8
2020
8351
0.140
Why?
Attitude
1
2020
253
0.140
Why?
Lymphoma, Mantle-Cell
1
2018
36
0.140
Why?
Male
19
2025
73014
0.130
Why?
Prognosis
5
2019
4331
0.130
Why?
ROC Curve
2
2018
613
0.130
Why?
Radiotherapy
1
2018
209
0.130
Why?
Tretinoin
1
2018
114
0.130
Why?
Image Interpretation, Computer-Assisted
2
2016
295
0.120
Why?
Mediastinal Neoplasms
1
2017
54
0.120
Why?
Lymph Nodes
1
2019
511
0.120
Why?
Bone Marrow
1
2018
308
0.120
Why?
Software Validation
1
2016
9
0.120
Why?
Female
19
2025
79080
0.120
Why?
Solitary Pulmonary Nodule
1
2016
25
0.120
Why?
Neoadjuvant Therapy
2
2016
474
0.120
Why?
Lung Diseases
1
2023
787
0.120
Why?
Pulmonary Ventilation
3
2021
80
0.120
Why?
MAP Kinase Kinase Kinases
1
2016
70
0.110
Why?
Dacarbazine
1
2015
98
0.110
Why?
Octreotide
1
2015
23
0.110
Why?
Area Under Curve
1
2016
333
0.110
Why?
Disease-Free Survival
4
2019
777
0.110
Why?
Programmed Cell Death 1 Receptor
1
2017
268
0.110
Why?
Phenylurea Compounds
1
2015
122
0.110
Why?
Societies, Medical
1
2019
901
0.110
Why?
Carcinoma, Papillary, Follicular
1
2014
8
0.110
Why?
Quinolines
1
2015
191
0.100
Why?
Organometallic Compounds
1
2015
110
0.100
Why?
Glycolysis
1
2016
341
0.100
Why?
Proto-Oncogene Proteins B-raf
1
2016
230
0.100
Why?
Kaplan-Meier Estimate
1
2016
959
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1194
0.090
Why?
Case-Control Studies
1
2020
3633
0.090
Why?
Adult
9
2020
40821
0.090
Why?
Carcinoma
1
2014
225
0.090
Why?
Treatment Outcome
3
2016
11744
0.090
Why?
Imaging, Three-Dimensional
1
2016
578
0.090
Why?
Survival Rate
4
2019
2078
0.090
Why?
Bone and Bones
1
2015
318
0.090
Why?
Radiotherapy Dosage
2
2025
289
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2016
1996
0.090
Why?
Practice Guidelines as Topic
1
2019
1581
0.080
Why?
Sensitivity and Specificity
1
2016
1992
0.080
Why?
Inflammation
1
2023
2915
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2017
992
0.080
Why?
Carcinoma, Squamous Cell
1
2016
627
0.080
Why?
Perfusion
2
2023
244
0.080
Why?
Antibodies, Monoclonal
1
2017
1511
0.080
Why?
Prostatic Neoplasms
1
2015
972
0.070
Why?
Prospective Studies
4
2023
8087
0.060
Why?
Whole Body Imaging
2
2018
29
0.060
Why?
Postoperative Complications
1
2019
2962
0.060
Why?
United States
2
2022
16041
0.060
Why?
Antineoplastic Agents
1
2017
2218
0.060
Why?
Brain Neoplasms
1
2014
1324
0.050
Why?
Follow-Up Studies
3
2019
5397
0.050
Why?
Cardiotoxicity
1
2024
35
0.050
Why?
Albumins
1
2024
119
0.050
Why?
Melanoma, Experimental
1
2024
106
0.050
Why?
Tissue Distribution
1
2024
334
0.050
Why?
Algorithms
2
2025
1843
0.050
Why?
Magnetic Resonance Imaging
1
2015
3917
0.050
Why?
Receptors, Somatostatin
1
2022
24
0.050
Why?
Child
1
2023
22638
0.050
Why?
Respiration
1
2023
207
0.040
Why?
Immunotherapy, Adoptive
1
2026
356
0.040
Why?
Ligands
1
2022
676
0.040
Why?
Pulmonary Atelectasis
1
2018
15
0.040
Why?
Peptides
1
2024
991
0.030
Why?
Europe
1
2019
420
0.030
Why?
Biological Transport
1
2019
423
0.030
Why?
Thyroglobulin
1
2018
28
0.030
Why?
Observer Variation
1
2018
355
0.030
Why?
Occipital Bone
1
2017
18
0.030
Why?
Parotid Gland
1
2017
17
0.030
Why?
Axilla
1
2017
51
0.030
Why?
Respiratory Function Tests
1
2018
543
0.030
Why?
Survival Analysis
1
2020
1372
0.030
Why?
Neck
1
2017
107
0.030
Why?
Cell Line, Tumor
1
2024
3538
0.030
Why?
Medicare
1
2022
907
0.030
Why?
Response Evaluation Criteria in Solid Tumors
1
2016
21
0.030
Why?
Radiology
1
2018
175
0.030
Why?
Heart
1
2020
624
0.030
Why?
Maximum Tolerated Dose
1
2015
216
0.030
Why?
Fluorouracil
1
2016
231
0.030
Why?
Tumor Burden
1
2016
326
0.030
Why?
Myocardium
1
2020
948
0.030
Why?
Recurrence
1
2017
1125
0.030
Why?
Carcinoma, Papillary
1
2014
83
0.020
Why?
Cisplatin
1
2016
346
0.020
Why?
Neoplasm Metastasis
1
2016
693
0.020
Why?
Preoperative Care
1
2016
375
0.020
Why?
Mice, Inbred C57BL
1
2024
6021
0.020
Why?
Analysis of Variance
1
2016
1293
0.020
Why?
Adolescent
3
2018
22451
0.020
Why?
Research Design
1
2018
1139
0.020
Why?
Biopsy
1
2015
1073
0.020
Why?
Ultrasonography
1
2015
788
0.020
Why?
Dose-Response Relationship, Drug
1
2015
2018
0.020
Why?
Reproducibility of Results
1
2018
3396
0.020
Why?
Predictive Value of Tests
1
2016
2097
0.020
Why?
Young Adult
2
2018
14240
0.020
Why?
Protein Kinase Inhibitors
1
2016
982
0.020
Why?
Cohort Studies
1
2018
6045
0.020
Why?
Mice
1
2024
18266
0.020
Why?
Mutation
1
2016
4082
0.010
Why?
Animals
1
2024
38030
0.010
Why?
Kwak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)